newsfilter
← Latest News
GlobeNewswire·

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE:EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply